Daniel, Domingo .
HRN: 11-75-88 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/02/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/02/2024
05/09/2024
IV
300 Mg
Q6h
Laceration
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes